2025 ASCO Annual Meeting

May 30 – June 2 | Booth #35123 | Chicago, IL

Meet Our Experts at Booth #35123

The oncology community will be at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Friday, May 30 – Monday, June 2, 2025 in Chicago, Illinois. 

Stop by booth #35123 to connect with our hematology and oncology clinical development experts. Our dedicated team will be there to discuss how to support your upcoming study from trial design and delivery to commercial optimization.

 

Attending Team:

Lyon Gleich, MD, FACS

Lyon Gleich, MD, FACS

Senior Vice President, Hematology & Oncology
Blythe Thomson, MD

Blythe Thomson, MD

Senior Vice President, Hematology & Oncology
Francis LeBlanc, MD

Francis LeBlanc, MD

Medical Director, Hematology & Oncology
Debbie Elliott, PhD

Debbie Elliott, PhD

Vice President, Clinical Trial Management
Jennifer Cutter, PhD

Jennifer Cutter, PhD

Senior Executive Director, Clinical Trial Management
Gianina Nixon, BS

Gianina Nixon, BS

Director, Clinical Trial Management
Chris Huth, PhD

Chris Huth, PhD

Senior Clinical Trial Manager
Scott Holland, PhD

Scott Holland, PhD

Senior Director, Core Lab Scientific Affairs

Request a Meeting at ASCO

"*" indicates required fields

Request a meeting to discuss your specific challenges or learn how we can help make intelligent connections to accelerate hematology clinical breakthroughs.

Your Next Breakthrough Starts Here

HEMATOLOGY & ONCOLOGY CRO

Through our proven full-service outsourcing model, Medpace consistently delivers high-quality results, showcasing profound expertise in managing Phase I-IV trials. Operating in 44 countries, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.

  • Led by a team of medical, operational, and regulatory experts experienced in hematology and oncology
  • Integrated services and systems through out wholly-owned Central Laboratories, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab, and Phase I Unit, in addition to our Clinical Trial Management System
  • Preferred provider relationships with key sites, expediting site start-up, enhancing recruitment, and maximizing trial efficacy
  • Experience in targeted, advanced, and radiation therapies
Hematology & Oncology Icon - Navy